Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Market Research Report
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Market Research Report
1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Introduction and Market Overview
- 1.1 Objectives of the Study
- 1.2 Definition of Chimeric Antigen Receptor (CAR) T-Cell Therapy
- 1.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Scope and Market Size Estimation
- 1.3.1 Market Concentration Ratio and Market Maturity Analysis
- 1.3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) and Growth Rate from 2017-2027
- 1.4 Market Segmentation
- 1.4.1 Types of Chimeric Antigen Receptor (CAR) T-Cell Therapy
- 1.4.2 Applications of Chimeric Antigen Receptor (CAR) T-Cell Therapy
- 1.4.3 Research Regions
- 1.4.3.1 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value ($) and Growth Rate (2017-2022)
- 1.4.3.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value ($) and Growth Rate (2017-2022)
- 1.4.3.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value ($) and Growth Rate (2017-2022)
- 1.4.3.4 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value ($) and Growth Rate (2017-2022)
- 1.4.3.5 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value ($) and Growth Rate (2017-2022)
- 1.4.3.6 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value ($) and Growth Rate (2017-2022)
- 1.4.3.7 South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value ($) and Growth Rate (2017-2022)
- 1.5 Market Dynamics
- 1.5.1 Drivers
- 1.5.1.1 Emerging Countries of Chimeric Antigen Receptor (CAR) T-Cell Therapy
- 1.5.1.2 Growing Market of Chimeric Antigen Receptor (CAR) T-Cell Therapy
- 1.5.2 Limitations
- 1.5.3 Opportunities
- 1.5.1 Drivers
- 1.6 Industry News and Policies by Regions
- 1.6.1 Industry News
- 1.6.2 Industry Policies
2 Industry Chain Analysis
- 2.1 Upstream Raw Material Suppliers of Chimeric Antigen Receptor (CAR) T-Cell Therapy Analysis
- 2.2 Major Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy
- 2.2.1 Major Players Manufacturing Base and Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy in 2021
- 2.2.2 Major Players Product Types in 2021
- 2.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Manufacturing Cost Structure Analysis
- 2.3.1 Production Process Analysis
- 2.3.2 Manufacturing Cost Structure of Chimeric Antigen Receptor (CAR) T-Cell Therapy
- 2.3.3 Raw Material Cost of Chimeric Antigen Receptor (CAR) T-Cell Therapy
- 2.3.4 Labor Cost of Chimeric Antigen Receptor (CAR) T-Cell Therapy
- 2.4 Market Channel Analysis of Chimeric Antigen Receptor (CAR) T-Cell Therapy
- 2.5 Major Downstream Buyers of Chimeric Antigen Receptor (CAR) T-Cell Therapy Analysis
3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Type
- 3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) and Market Share by Type (2017-2022)
- 3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production and Market Share by Type (2017-2022)
- 3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) and Growth Rate by Type (2017-2022)
- 3.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price Analysis by Type (2017-2022)
4 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Application
- 4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Market Share by Application (2017-2022)
- 4.2 Downstream Buyers by Application
- 4.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate by Application (2017-2022)
5 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($) by Region (2017-2022)
- 5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) and Market Share by Region (2017-2022)
- 5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production and Market Share by Region (2017-2022)
- 5.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
- 5.4 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
- 5.5 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
- 5.6 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
- 5.7 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
- 5.8 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
- 5.9 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
- 5.10 South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
6 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import by Regions (2017-2022)
- 6.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption by Regions (2017-2022)
- 6.2 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import (2017-2022)
- 6.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import (2017-2022)
- 6.4 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import (2017-2022)
- 6.5 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import (2017-2022)
- 6.6 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import (2017-2022)
- 6.7 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import (2017-2022)
- 6.8 South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import (2017-2022)
7 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and SWOT Analysis by Regions
- 7.1 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and SWOT Analysis
- 7.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and SWOT Analysis
- 7.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and SWOT Analysis
- 7.4 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and SWOT Analysis
- 7.5 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and SWOT Analysis
- 7.6 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and SWOT Analysis
- 7.7 South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and SWOT Analysis
8 Competitive Landscape
- 8.1 Competitive Profile
- 8.2 Eureka Therapeutics Inc.
- 8.2.1 Company Profiles
- 8.2.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.2.3 Eureka Therapeutics Inc. Production, Value ($), Price, Gross Margin 2017-2022
- 8.2.4 Eureka Therapeutics Inc. Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.3 Cellectis
- 8.3.1 Company Profiles
- 8.3.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.3.3 Cellectis Production, Value ($), Price, Gross Margin 2017-2022
- 8.3.4 Cellectis Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.4 Editas Medicine Inc.
- 8.4.1 Company Profiles
- 8.4.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.4.3 Editas Medicine Inc. Production, Value ($), Price, Gross Margin 2017-2022
- 8.4.4 Editas Medicine Inc. Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.5 F. Hoffman La Roche AG
- 8.5.1 Company Profiles
- 8.5.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.5.3 F. Hoffman La Roche AG Production, Value ($), Price, Gross Margin 2017-2022
- 8.5.4 F. Hoffman La Roche AG Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.6 Takeda Pharmaceuticals
- 8.6.1 Company Profiles
- 8.6.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.6.3 Takeda Pharmaceuticals Production, Value ($), Price, Gross Margin 2017-2022
- 8.6.4 Takeda Pharmaceuticals Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.7 Mustang Bio Inc.
- 8.7.1 Company Profiles
- 8.7.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.7.3 Mustang Bio Inc. Production, Value ($), Price, Gross Margin 2017-2022
- 8.7.4 Mustang Bio Inc. Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.8 Medimmune Llc/Astrazeneca
- 8.8.1 Company Profiles
- 8.8.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.8.3 Medimmune Llc/Astrazeneca Production, Value ($), Price, Gross Margin 2017-2022
- 8.8.4 Medimmune Llc/Astrazeneca Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.9 Bluebird Bio
- 8.9.1 Company Profiles
- 8.9.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.9.3 Bluebird Bio Production, Value ($), Price, Gross Margin 2017-2022
- 8.9.4 Bluebird Bio Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.10 Protheragen Inc.
- 8.10.1 Company Profiles
- 8.10.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.10.3 Protheragen Inc. Production, Value ($), Price, Gross Margin 2017-2022
- 8.10.4 Protheragen Inc. Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.11 Celyad SA
- 8.11.1 Company Profiles
- 8.11.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.11.3 Celyad SA Production, Value ($), Price, Gross Margin 2017-2022
- 8.11.4 Celyad SA Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.12 Servier Laboratories
- 8.12.1 Company Profiles
- 8.12.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.12.3 Servier Laboratories Production, Value ($), Price, Gross Margin 2017-2022
- 8.12.4 Servier Laboratories Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.13 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.)
- 8.13.1 Company Profiles
- 8.13.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.13.3 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Production, Value ($), Price, Gross Margin 2017-2022
- 8.13.4 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.14 Formula Pharmaceuticals Inc.
- 8.14.1 Company Profiles
- 8.14.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.14.3 Formula Pharmaceuticals Inc. Production, Value ($), Price, Gross Margin 2017-2022
- 8.14.4 Formula Pharmaceuticals Inc. Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.15 Gilead Sciences
- 8.15.1 Company Profiles
- 8.15.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.15.3 Gilead Sciences Production, Value ($), Price, Gross Margin 2017-2022
- 8.15.4 Gilead Sciences Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.16 Noile-Immune Biotech
- 8.16.1 Company Profiles
- 8.16.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Introduction
- 8.16.3 Noile-Immune Biotech Production, Value ($), Price, Gross Margin 2017-2022
- 8.16.4 Noile-Immune Biotech Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
- 8.17 Juno Therapeutics Inc. (A Celgene Company)
- 8.18 Amgen
- 8.19 Puretech Health
- 8.20 Bellicum Phamaceuticals
- 8.21 Novartis AG
- 8.22 Avacta Life Sciences Ltd.
- 8.23 Transgene SA
- 8.24 Shire Pharmaceuticals Inc.
- 8.25 Celgene Corp.
- 8.26 iCell Gene Therapeutics
9 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis and Forecast by Type and Application
- 9.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Value ($) & Volume Forecast, by Type (2022-2027)
- 9.1.1 Acute Lymphoblastic Leukemia (ALL) Market Value ($) and Volume Forecast (2022-2027)
- 9.1.2 Advanced Lymphomas Market Value ($) and Volume Forecast (2022-2027)
- 9.1.3 Others Market Value ($) and Volume Forecast (2022-2027)
- 9.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Value ($) & Volume Forecast, by Application (2022-2027)
- 9.2.1 Children Market Value ($) and Volume Forecast (2022-2027)
- 9.2.2 Adult Market Value ($) and Volume Forecast (2022-2027)
10 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis and Forecast by Region
- 10.1 North America Market Value ($) and Consumption Forecast (2022-2027)
- 10.2 Europe Market Value ($) and Consumption Forecast (2022-2027)
- 10.3 China Market Value ($) and Consumption Forecast (2022-2027)
- 10.4 Japan Market Value ($) and Consumption Forecast (2022-2027)
- 10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2022-2027)
- 10.6 India Market Value ($) and Consumption Forecast (2022-2027)
- 10.7 South America Market Value ($) and Consumption Forecast (2022-2027)
11 New Project Feasibility Analysis
- 11.1 Industry Barriers and New Entrants SWOT Analysis
- 11.2 Analysis and Suggestions on New Project Investment
12 Research Finding and Conclusion
13 Appendix
- 13.1 Discussion Guide
- 13.2 Knowledge Store: Maia Subscription Portal
- 13.3 Research Data Source
- 13.4 Research Assumptions and Acronyms Used
List of Tables and Figures
Figure Product Picture of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Table Product Specification of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Figure Market Concentration Ratio and Market Maturity Analysis of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) and Growth Rate from 2017-2027
Table Different Types of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) Segment by Type from 2017-2022
Figure Acute Lymphoblastic Leukemia (ALL) Picture
Figure Advanced Lymphomas Picture
Figure Others Picture
Table Different Applications of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) Segment by Applications from 2017-2022
Figure Children Picture
Figure Adult Picture
Table Research Regions of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Figure North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value ($) and Growth Rate (2017-2022)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value ($) and Growth Rate (2017-2022)
Table China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value ($) and Growth Rate (2017-2022)
Table Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value ($) and Growth Rate (2017-2022)
Table Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value ($) and Growth Rate (2017-2022)
Table India Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value ($) and Growth Rate (2017-2022)
Table South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value ($) and Growth Rate (2017-2022)
Table Emerging Countries of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Table Growing Market of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Figure Industry Chain Analysis of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Table Upstream Raw Material Suppliers of Chimeric Antigen Receptor (CAR) T-Cell Therapy with Contact Information
Table Major Players Manufacturing Base and Market Share ($) of Chimeric Antigen Receptor (CAR) T-Cell Therapy in 2021
Table Major Players Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Types in 2021
Figure Production Process of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Figure Manufacturing Cost Structure of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Figure Channel Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Table Major Distributors of Chimeric Antigen Receptor (CAR) T-Cell Therapy with Contact Information
Table Major Downstream Buyers of Chimeric Antigen Receptor (CAR) T-Cell Therapy with Contact Information
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) by Type (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) Share by Type (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) Share by Type (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production by Type (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Share by Type (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Share by Type (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) and Growth Rate of Acute Lymphoblastic Leukemia (ALL)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) and Growth Rate of Advanced Lymphomas
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) and Growth Rate of Others
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price by Type (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption by Application (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Market Share by Application (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Market Share by Application (2017-2022)
Table Downstream Buyers Introduction by Application
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate of Children (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate of Adult (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) by Region (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) Market Share by Region (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Value ($) Market Share by Region (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production by Region (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Market Share by Region (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Market Share by Region (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
Table North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
Table Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
Table China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
Table Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
Table Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
Table India Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
Table South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Value ($), Price and Gross Margin (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption by Regions (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Share by Regions (2017-2022)
Table North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import (2017-2022)
Table Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import (2017-2022)
Table China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import (2017-2022)
Table Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import (2017-2022)
Table Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import (2017-2022)
Table India Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import (2017-2022)
Table South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export, Import (2017-2022)
Figure North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production and Growth Rate Analysis
Figure North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate Analysis
Figure North America Chimeric Antigen Receptor (CAR) T-Cell Therapy SWOT Analysis
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Production and Growth Rate Analysis
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate Analysis
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy SWOT Analysis
Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production and Growth Rate Analysis
Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate Analysis
Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy SWOT Analysis
Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Production and Growth Rate Analysis
Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate Analysis
Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy SWOT Analysis
Figure Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Production and Growth Rate Analysis
Figure Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate Analysis
Figure Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy SWOT Analysis
Figure India Chimeric Antigen Receptor (CAR) T-Cell Therapy Production and Growth Rate Analysis
Figure India Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate Analysis
Figure India Chimeric Antigen Receptor (CAR) T-Cell Therapy SWOT Analysis
Figure South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Production and Growth Rate Analysis
Figure South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate Analysis
Figure South America Chimeric Antigen Receptor (CAR) T-Cell Therapy SWOT Analysis
Figure Top 3 Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies
Figure Top 6 Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Companies
Table Mergers, Acquisitions and Expansion Analysis
Table Company Profiles
Table Product Introduction
Table Eureka Therapeutics Inc. Production, Value ($), Price, Gross Margin 2017-2022
Figure Eureka Therapeutics Inc. Production and Growth Rate
Figure Eureka Therapeutics Inc. Value ($) Market Share 2017-2022
Figure Eureka Therapeutics Inc. Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Cellectis Production, Value ($), Price, Gross Margin 2017-2022
Figure Cellectis Production and Growth Rate
Figure Cellectis Value ($) Market Share 2017-2022
Figure Cellectis Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Editas Medicine Inc. Production, Value ($), Price, Gross Margin 2017-2022
Figure Editas Medicine Inc. Production and Growth Rate
Figure Editas Medicine Inc. Value ($) Market Share 2017-2022
Figure Editas Medicine Inc. Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table F. Hoffman La Roche AG Production, Value ($), Price, Gross Margin 2017-2022
Figure F. Hoffman La Roche AG Production and Growth Rate
Figure F. Hoffman La Roche AG Value ($) Market Share 2017-2022
Figure F. Hoffman La Roche AG Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Takeda Pharmaceuticals Production, Value ($), Price, Gross Margin 2017-2022
Figure Takeda Pharmaceuticals Production and Growth Rate
Figure Takeda Pharmaceuticals Value ($) Market Share 2017-2022
Figure Takeda Pharmaceuticals Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Mustang Bio Inc. Production, Value ($), Price, Gross Margin 2017-2022
Figure Mustang Bio Inc. Production and Growth Rate
Figure Mustang Bio Inc. Value ($) Market Share 2017-2022
Figure Mustang Bio Inc. Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Medimmune Llc/Astrazeneca Production, Value ($), Price, Gross Margin 2017-2022
Figure Medimmune Llc/Astrazeneca Production and Growth Rate
Figure Medimmune Llc/Astrazeneca Value ($) Market Share 2017-2022
Figure Medimmune Llc/Astrazeneca Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Bluebird Bio Production, Value ($), Price, Gross Margin 2017-2022
Figure Bluebird Bio Production and Growth Rate
Figure Bluebird Bio Value ($) Market Share 2017-2022
Figure Bluebird Bio Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Protheragen Inc. Production, Value ($), Price, Gross Margin 2017-2022
Figure Protheragen Inc. Production and Growth Rate
Figure Protheragen Inc. Value ($) Market Share 2017-2022
Figure Protheragen Inc. Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Celyad SA Production, Value ($), Price, Gross Margin 2017-2022
Figure Celyad SA Production and Growth Rate
Figure Celyad SA Value ($) Market Share 2017-2022
Figure Celyad SA Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Servier Laboratories Production, Value ($), Price, Gross Margin 2017-2022
Figure Servier Laboratories Production and Growth Rate
Figure Servier Laboratories Value ($) Market Share 2017-2022
Figure Servier Laboratories Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Production, Value ($), Price, Gross Margin 2017-2022
Figure Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Production and Growth Rate
Figure Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Value ($) Market Share 2017-2022
Figure Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Formula Pharmaceuticals Inc. Production, Value ($), Price, Gross Margin 2017-2022
Figure Formula Pharmaceuticals Inc. Production and Growth Rate
Figure Formula Pharmaceuticals Inc. Value ($) Market Share 2017-2022
Figure Formula Pharmaceuticals Inc. Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Gilead Sciences Production, Value ($), Price, Gross Margin 2017-2022
Figure Gilead Sciences Production and Growth Rate
Figure Gilead Sciences Value ($) Market Share 2017-2022
Figure Gilead Sciences Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Noile-Immune Biotech Production, Value ($), Price, Gross Margin 2017-2022
Figure Noile-Immune Biotech Production and Growth Rate
Figure Noile-Immune Biotech Value ($) Market Share 2017-2022
Figure Noile-Immune Biotech Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Juno Therapeutics Inc. (A Celgene Company) Production, Value ($), Price, Gross Margin 2017-2022
Figure Juno Therapeutics Inc. (A Celgene Company) Production and Growth Rate
Figure Juno Therapeutics Inc. (A Celgene Company) Value ($) Market Share 2017-2022
Figure Juno Therapeutics Inc. (A Celgene Company) Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Amgen Production, Value ($), Price, Gross Margin 2017-2022
Figure Amgen Production and Growth Rate
Figure Amgen Value ($) Market Share 2017-2022
Figure Amgen Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Puretech Health Production, Value ($), Price, Gross Margin 2017-2022
Figure Puretech Health Production and Growth Rate
Figure Puretech Health Value ($) Market Share 2017-2022
Figure Puretech Health Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Bellicum Phamaceuticals Production, Value ($), Price, Gross Margin 2017-2022
Figure Bellicum Phamaceuticals Production and Growth Rate
Figure Bellicum Phamaceuticals Value ($) Market Share 2017-2022
Figure Bellicum Phamaceuticals Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Novartis AG Production, Value ($), Price, Gross Margin 2017-2022
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Value ($) Market Share 2017-2022
Figure Novartis AG Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Avacta Life Sciences Ltd. Production, Value ($), Price, Gross Margin 2017-2022
Figure Avacta Life Sciences Ltd. Production and Growth Rate
Figure Avacta Life Sciences Ltd. Value ($) Market Share 2017-2022
Figure Avacta Life Sciences Ltd. Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Transgene SA Production, Value ($), Price, Gross Margin 2017-2022
Figure Transgene SA Production and Growth Rate
Figure Transgene SA Value ($) Market Share 2017-2022
Figure Transgene SA Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Shire Pharmaceuticals Inc. Production, Value ($), Price, Gross Margin 2017-2022
Figure Shire Pharmaceuticals Inc. Production and Growth Rate
Figure Shire Pharmaceuticals Inc. Value ($) Market Share 2017-2022
Figure Shire Pharmaceuticals Inc. Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table Celgene Corp. Production, Value ($), Price, Gross Margin 2017-2022
Figure Celgene Corp. Production and Growth Rate
Figure Celgene Corp. Value ($) Market Share 2017-2022
Figure Celgene Corp. Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Company Profiles
Table Product Introduction
Table iCell Gene Therapeutics Production, Value ($), Price, Gross Margin 2017-2022
Figure iCell Gene Therapeutics Production and Growth Rate
Figure iCell Gene Therapeutics Value ($) Market Share 2017-2022
Figure iCell Gene Therapeutics Market Share of Chimeric Antigen Receptor (CAR) T-Cell Therapy Segmented by Region in 2021
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Value ($) Forecast, by Type
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Volume Forecast, by Type
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Value ($) and Growth Rate Forecast of Acute Lymphoblastic Leukemia (ALL) (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Volume and Growth Rate Forecast of Acute Lymphoblastic Leukemia (ALL) (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Value ($) and Growth Rate Forecast of Advanced Lymphomas (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Volume and Growth Rate Forecast of Advanced Lymphomas (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Value ($) and Growth Rate Forecast of Others (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Volume and Growth Rate Forecast of Othe
The Chimeric Antigen Receptor (CAR) T-Cell Therapy market revenue was xx.xx Million USD in 2017, grew to xx.xx Million USD in 2021, and will reach xx.xx Million USD in 2027, with a CAGR of x.x% during 2022-2027. Based on the Chimeric Antigen Receptor (CAR) T-Cell Therapy industrial chain, this report mainly elaborates the definition, types, applications and major players of Chimeric Antigen Receptor (CAR) T-Cell Therapy market in details. Deep analysis about market status (2017-2022), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2022-2027), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Chimeric Antigen Receptor (CAR) T-Cell Therapy market.
The Chimeric Antigen Receptor (CAR) T-Cell Therapy market can be split based on product types, major applications, and important regions.
Major Players in Chimeric Antigen Receptor (CAR) T-Cell Therapy market are:
Eureka Therapeutics Inc.
Cellectis
Editas Medicine Inc.
F. Hoffman La Roche AG
Takeda Pharmaceuticals
Mustang Bio Inc.
Medimmune Llc/Astrazeneca
Bluebird Bio
Protheragen Inc.
Celyad SA
Servier Laboratories
Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.)
Formula Pharmaceuticals Inc.
Gilead Sciences
Noile-Immune Biotech
Juno Therapeutics Inc. (A Celgene Company)
Amgen
Puretech Health
Bellicum Phamaceuticals
Novartis AG
Avacta Life Sciences Ltd.
Transgene SA
Shire Pharmaceuticals Inc.
Celgene Corp.
iCell Gene Therapeutics
Major Regions that plays a vital role in Chimeric Antigen Receptor (CAR) T-Cell Therapy market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others
Most important types of Chimeric Antigen Receptor (CAR) T-Cell Therapy products covered in this report are:
Acute Lymphoblastic Leukemia (ALL)
Advanced Lymphomas
Others
Most widely used downstream fields of Chimeric Antigen Receptor (CAR) T-Cell Therapy market covered in this report are:
Children
Adult
There are 13 Chapters to thoroughly display the Chimeric Antigen Receptor (CAR) T-Cell Therapy market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.
Chapter 1: Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.
Chapter 2: Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.
Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Chimeric Antigen Receptor (CAR) T-Cell Therapy.
Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Chimeric Antigen Receptor (CAR) T-Cell Therapy.
Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Chimeric Antigen Receptor (CAR) T-Cell Therapy by Regions (2017-2022).
Chapter 6: Chimeric Antigen Receptor (CAR) T-Cell Therapy Production, Consumption, Export and Import by Regions (2017-2022).
Chapter 7: Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and SWOT Analysis by Regions.
Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy.
Chapter 9: Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis and Forecast by Type and Application (2022-2027).
Chapter 10: Market Analysis and Forecast by Regions (2022-2027).
Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.
Chapter 12: Market Conclusion of the Whole Report.
Chapter 13: Appendix Such as Methodology and Data Resources of This Research.